Oxford BioMedica PLC (OXB)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

522.00p

Buy

527.00p

arrow-up9.00p (+1.75%)

Prices updated at 09 Oct 2026, 14:28 BST

Prices minimum 15 mins delay

Prices in GBX

Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno ...

FTSE All-Share

1.12%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

09 Oct 2026

06 Oct 2026

02 Oct 2026

01 Oct 2026

28 Sep 2026

25 Sep 2026

24 Sep 2026

22 Sep 2026

Key dates

	Forecast date
Half yearly results	Sep 2027
Annual general meeting	May 2027
Annual report	Mar 2027
Final results	Mar 2027

	Previous date
Half yearly results	Sep 2026
Annual general meeting	May 2026
Annual report	Mar 2026
Final results	Mar 2026

Company reports

31 Dec 2025

Annual Report

30 Jun 2012

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.